Compagnie Lombard Odier S Cm A Biogen Inc. Transaction History

Compagnie Lombard Odier S Cm A

  • $6.12 Billion
  • Q3 2024

A detailed history of Compagnie Lombard Odier S Cm A transactions in Biogen Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 420 shares of BIIB stock, worth $72,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares
420
Previous 400 5.0%
Holding current value
$72,991
Previous $92,000 11.96%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
BUY
$189.07 - $236.8 $3,781 - $4,736
20 Added 5.0%
420 $81,000
Q3 2023

Oct 23, 2023
BUY
$253.3 - $285.89 $54,459 - $61,466
215 Added 116.22%
400 $102,000
Q2 2023

Aug 07, 2023
SELL
$275.25 - $318.06 $55,050 - $63,612
-200 Reduced 51.95%
185 $52,000
Q1 2023

May 01, 2023
SELL
$256.56 - $292.34 $131,358 - $149,678
-512 Reduced 57.08%
385 $107,000
Q4 2022

Feb 13, 2023
BUY
$252.44 - $306.72 $129,249 - $157,040
512 Added 132.99%
897 $248,000
Q3 2022

Nov 09, 2022
BUY
$194.69 - $268.46 $36,017 - $49,665
185 Added 92.5%
385 $103,000
Q1 2022

Apr 27, 2022
BUY
$193.77 - $244.14 $38,754 - $48,828
200 New
200 $42,000
Q3 2021

Oct 28, 2021
SELL
$282.99 - $369.05 $28,299 - $36,905
-100 Closed
0 $0
Q2 2021

Jul 15, 2021
SELL
$259.0 - $414.71 $12,950 - $20,735
-50 Reduced 33.33%
100 $35,000
Q1 2021

Apr 23, 2021
SELL
$242.95 - $284.63 $36,442 - $42,694
-150 Reduced 50.0%
150 $42,000
Q2 2020

Aug 14, 2020
BUY
$258.66 - $342.55 $51,732 - $68,510
200 Added 200.0%
300 $81,000
Q4 2019

Feb 13, 2020
SELL
$220.06 - $304.07 $67,558 - $93,349
-307 Reduced 75.43%
100 $30,000
Q2 2019

Aug 14, 2019
SELL
$219.29 - $241.72 $413,580 - $455,883
-1,886 Reduced 82.25%
407 $95,000
Q1 2019

May 13, 2019
SELL
$216.71 - $338.96 $238,381 - $372,856
-1,100 Reduced 32.42%
2,293 $542,000
Q4 2018

Feb 13, 2019
BUY
$278.5 - $352.75 $4,177 - $5,291
15 Added 0.44%
3,393 $1.02 Million
Q3 2018

Nov 13, 2018
BUY
$293.51 - $383.83 $594,357 - $777,255
2,025 Added 149.67%
3,378 $1.19 Million
Q2 2018

Aug 10, 2018
BUY
$257.52 - $306.91 $38,628 - $46,036
150 Added 12.47%
1,353 $393,000
Q1 2018

May 11, 2018
SELL
$260.13 - $367.91 $9,104 - $12,876
-35 Reduced 2.83%
1,203 $329,000
Q4 2017

Feb 13, 2018
SELL
$307.64 - $344.58 $153,820 - $172,290
-500 Reduced 28.77%
1,238 $394,000
Q3 2017

Nov 14, 2017
SELL
$281.15 - $329.69 $337,942 - $396,287
-1,202 Reduced 40.88%
1,738 $544,000
Q2 2017

Aug 14, 2017
BUY
N/A
2,940
2,940 $796,000

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email